This inventor holds 1 USPTO granted patent. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: The Innovative Contributions of Takahiro Kanda
Introduction
Takahiro Kanda is a notable inventor based in Oyama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on isoquinolinone derivatives. His research focuses on developing compounds with potential therapeutic applications.
Latest Patents
One of Takahiro Kanda's key patents is for a compound titled "4-(Substituted aryl)-5-hydroxyisoquinolinone derivative." This invention provides 4-substituted aryl-5-hydroxyisoquinolinone derivatives and their pharmacologically acceptable addition salts, which exhibit an excellent inhibitory effect on poly (ADP-ribose) synthetase. The derivatives are represented by a general formula (1) and hold promise for various medical applications.
Career Highlights
Takahiro Kanda is currently associated with Kyorin Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has contributed to the company's portfolio of innovative pharmaceutical products.
Collaborations
Takahiro has collaborated with notable colleagues, including Futoshi Shiga and Tetsuya Kimura. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Takahiro Kanda's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to impact the development of new therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile